Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Gómez-Labrador C, Ricart E, Iborra M, Iglesias E, Martín-Arranz MD, de Castro L, De Francisco R, García-Alonso FJ, Sanahuja A, Gargallo-Puyuelo CJ, Mesonero F, Casanova MJ, Mañosa M, Rivero M, Calvo M, Sierra-Ausin M, González-Muñoza C, Calvet X, García-López S, Guardiola J, Arias García L, Márquez-Mosquera L, Gutiérrez A, Zabana Y, Navarro-Llavat M, Lorente Poyatos R, Piqueras M, Torrealba L, Bermejo F, Ponferrada-Díaz Á, Pérez-Calle JL, Barreiro-de Acosta M, Tejido C, Cabriada JL, Marín-Jiménez I, Roncero Ó, Ber Y, Fernández-Salazar L, Camps Aler B, Lucendo AJ, Llaó J, Bujanda L, Muñoz Villafranca C, Domènech E, Chaparro M, Gisbert JP

Open source

DOI
10.3390/pharmaceutics16050629
Published
2024 May 8
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics16050629,
  title = {Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.},
  author = {Gómez-Labrador C and Ricart E and Iborra M and Iglesias E and Martín-Arranz MD and de Castro L and De Francisco R and García-Alonso FJ and Sanahuja A and Gargallo-Puyuelo CJ and Mesonero F and Casanova MJ and Mañosa M and Rivero M and Calvo M and Sierra-Ausin M and González-Muñoza C and Calvet X and García-López S and Guardiola J and Arias García L and Márquez-Mosquera L and Gutiérrez A and Zabana Y and Navarro-Llavat M and Lorente Poyatos R and Piqueras M and Torrealba L and Bermejo F and Ponferrada-Díaz Á and Pérez-Calle JL and Barreiro-de Acosta M and Tejido C and Cabriada JL and Marín-Jiménez I and Roncero Ó and Ber Y and Fernández-Salazar L and Camps Aler B and Lucendo AJ and Llaó J and Bujanda L and Muñoz Villafranca C and Domènech E and Chaparro M and Gisbert JP},
  year = {2024},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics16050629},
  url = {https://doi.org/10.3390/pharmaceutics16050629}
}

RIS

TY  - JOUR
TI  - Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
AU  - Gómez-Labrador C
AU  - Ricart E
AU  - Iborra M
AU  - Iglesias E
AU  - Martín-Arranz MD
AU  - de Castro L
AU  - De Francisco R
AU  - García-Alonso FJ
AU  - Sanahuja A
AU  - Gargallo-Puyuelo CJ
AU  - Mesonero F
AU  - Casanova MJ
AU  - Mañosa M
AU  - Rivero M
AU  - Calvo M
AU  - Sierra-Ausin M
AU  - González-Muñoza C
AU  - Calvet X
AU  - García-López S
AU  - Guardiola J
AU  - Arias García L
AU  - Márquez-Mosquera L
AU  - Gutiérrez A
AU  - Zabana Y
AU  - Navarro-Llavat M
AU  - Lorente Poyatos R
AU  - Piqueras M
AU  - Torrealba L
AU  - Bermejo F
AU  - Ponferrada-Díaz Á
AU  - Pérez-Calle JL
AU  - Barreiro-de Acosta M
AU  - Tejido C
AU  - Cabriada JL
AU  - Marín-Jiménez I
AU  - Roncero Ó
AU  - Ber Y
AU  - Fernández-Salazar L
AU  - Camps Aler B
AU  - Lucendo AJ
AU  - Llaó J
AU  - Bujanda L
AU  - Muñoz Villafranca C
AU  - Domènech E
AU  - Chaparro M
AU  - Gisbert JP
PY  - 2024
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics16050629
UR  - https://doi.org/10.3390/pharmaceutics16050629
ER  -

APA

C, G., E, R., M, I., E, I., MD, M., L, D. C., R, D. F., FJ, G., A, S., CJ, G., F, M., MJ, C., M, M., M, R., M, C., M, S., C, G., X, C., S, G., J, G., L, A. G., L, M., A, G., Y, Z., M, N., R, L. P., M, P., L, T., F, B., Á, P., JL, P., M, B. A., C, T., JL, C., I, M., Ó, R., Y, B., L, F., B, C. A., AJ, L., J, L., L, B., C, M. V., E, D., M, C., & JP, G. (2024). Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16050629

Source records